The Expiry Date on the Paper: Why a CBD Certificate of Analysis Needs Its Own Diary

The document and the oil do not age at the same rate

A certificate of analysis is often treated as though it were welded to the batch it describes. In practice it is a laboratory record of a sample at a point in time. The oil, meanwhile, keeps moving: cannabinoid profiles drift, carrier oils oxidise, packaging interacts with contents, and storage conditions leave their mark. By the time a pallet is broken down for repackaging or a retailer asks for assurance before listing, the certificate may be months old and the batch may no longer behave as the paper says it did.

For UK trade buyers, the commercial risk is not that certificates are dishonest. It is that they are finite. A CoA issued in January can be entirely accurate and still be a poor basis for a retail release in September. The question is not whether the document was valid when written, but whether it remains a fair description of the goods now being moved. That distinction is the foundation of a re-testing calendar.

What a certificate actually certifies

A well-constructed CoA tells you what a laboratory found in a sample drawn at a stated time, using a stated method, against stated limits. It may cover cannabinoid potency, THC and other controlled cannabinoids, heavy metals, pesticides, microbiological indicators, residual solvents and, where relevant, mycotoxins. It is evidence of a sampling event, not a warranty of future performance.

That point matters in wholesale because the sample itself may not be representative of the whole lot, and because the lot may be stored in conditions the laboratory never saw. A certificate that travels with a batch through several warehouses, a repackaging line and a distribution vehicle is being asked to do more than it can. The calendar is how a buyer closes that gap without pretending the original document is something it is not.

Why re-testing is not a bureaucratic reflex

CBD oil is not inert. Cannabinoids can degrade over time, particularly when exposed to light, heat and oxygen. Potency may fall; ratios between cannabinoids may shift; CBDa and CBD can behave differently depending on the matrix and storage history. Carrier oils bring their own stability profiles, and a product that was clear and within specification at release may develop off-notes or oxidative markers later. Packaging is not a neutral bystander either: closure integrity and migration behaviour can change the picture between the original test and the retail shelf.

None of this means every batch must be tested monthly. It means the interval should be justified. A re-testing calendar is a risk-management instrument, not a ritual. It should reflect the product type, the carrier, the packaging format, the storage conditions, the intended shelf life and the evidential demands of the customers being supplied.

Setting a validity window that can be defended

There is no single statutory re-test interval for CBD oil in the UK that fits every case. Trade buyers should therefore avoid treating any one number as gospel. A defensible window is built from stability evidence, storage conditions and the consequences of failure.

A sensible starting point is to ask the supplier for real-time stability data on the same formulation and pack format, not a generic assertion that the oil is stable for a stated period. Accelerated studies can be useful for screening, but they do not automatically substitute for real-time evidence, particularly where retail release depends on a potency claim. If the supplier cannot provide stability data, the buyer should shorten the interval and increase sampling. If the product is stored above the conditions used in the study, the window should shrink again.

The calendar should distinguish between the certificate's issue date, the batch manufacture date, the date of receipt, the date of repackaging and the date of retail release. These are not interchangeable. A batch received in March with a January certificate is not fresh in the same sense as a batch manufactured in March.

Contractual triggers for re-testing

A re-testing calendar is only as good as the contract behind it. UK trade buyers should write trigger points into supply agreements rather than relying on goodwill. Useful triggers include:

• On receipt: confirm identity and key markers against the supplier's CoA, especially where transit conditions are uncertain.
• Before repackaging: re-test if the batch is being decanted into a different container, because packaging and headspace change the storage environment.
• Before retail release: require a current certificate where the retailer's own due diligence demands it, or where the interval since the last test exceeds the agreed window.
• After a defined storage period: set a maximum interval, expressed in months, after which a fresh sample is required regardless of whether anything appears wrong.
• On complaint or adverse signal: treat a potency or sensory complaint as a trigger, not an inconvenience.
• On supplier or specification change: re-test if the carrier, flavour system, packaging supplier or extraction route changes, even if the product name does not.

The contract should also state who pays for re-testing, which laboratory is acceptable, what method is required and what happens if results fall outside specification. Without those clauses, the calendar becomes a suggestion.

The records that make 'still current' defensible

When a retailer or a local authority asks whether a batch is still within specification, the answer should be evidenced by a file, not a reassurance. That file should include the original CoA, the re-test certificates, the sampling records, the storage conditions, the chain of custody and a clear note of any deviation. Version control matters: a superseded certificate should be marked as such, not quietly replaced.

A re-test register is a practical tool. At minimum it should record the batch identifier, the product and pack format, the manufacture and expiry dates, the date of the last test, the next test due, the laboratory used, the result summary and the responsible person. It should be reviewed on a fixed cycle, not only when someone asks. The register is also useful evidence of a systematic approach, which is often what regulators and sophisticated retailers are looking for.

A workable pattern for UK wholesalers

A wholesaler handling several SKUs might adopt a tiered approach. High-risk formats, such as those in permeable or small-volume packaging, or products stored in less controlled conditions, could be re-tested at shorter intervals. Stable formats with strong real-time stability data could be placed on a longer cycle, provided the storage conditions are documented and audited. Every batch should have a named owner and a next-action date.

The calendar should also account for the commercial reality of slow-moving stock. A batch that sits in a warehouse for a year is not the same commercial object as one that moves in a month. If stock is ageing, the re-test decision should be made before a retailer asks, not after.

The paper is a starting point, not a conclusion

A certificate of analysis is essential, but it is not self-renewing. UK CBD trade buyers who treat it as a permanent passport will eventually find themselves explaining a gap between the document and the goods. Those who build a re-testing calendar, tie it to contractual triggers and keep the records in order will be better placed when a retailer, a distributor or a local authority asks the only question that matters: what is in the bottle now, and how do you know?

The answer should be a dated, sampled, laboratory-backed record — and a diary that shows the question was asked before it was put to you.